Abstract

BackgroundCandida is the commonest opportunistic fungi in human. Candida species cause diverse types of diseases. Vaginal candidiasis has been reported as one of the most common type of fungal diseases among pregnant women. However; In Ethiopia, due to scarcity of data, much has not been documented regarding the prevalence of Candida among pregnant women.ObjectiveThis study aimed to determine the prevalence, possible risk factors and antifungal susceptibility profile of Candida species among pregnant women attending Debre Markos Referral Hospital, Northwest Ethiopia.MethodA cross-sectional study was conducted from February to May 2017. A total of 384 pregnant women were included using a systematic random sampling technique. Vaginal specimens were collected, inoculated on Candida HiV eg culture Medium and incubated at 37 °C for 24 h.Colonies were identified using standard microbiological methods and selected for further Candida Species identification using Hi Chrome agar and germ tube test. Fungal suspensions were made and adjusted at 0.5% MacFarland standard. Modified Kirby-Bauer disk diffusion technique was used for antifungal susceptibility. Data was entered, cleaned using Ep info version 7.1and transported to Statistical Packages for Social Sciences (SPSS) version 21 for analysis. Descriptive statistics and logistic regression were performed. P. value < 0.05 at 95% confidence interval was considered as statistically significant.ResultFrom a total of 384 study participants, 96 (25%) were positive for Candida species. The predominant Candida species was Candida albicans 54(56.25%) followed by Candida krusei 21(21.9%), Candida glabrata 17(17.7%), Candida tropicalis 1(1%) and 3(3.1%) were other Candida species. Contraceptive use (AOR: 0.394; 95% CI = 0.20–0.74) and prolonged antibiotic uses (AOR: 0.393; 95% CI = 0.21–0.72) were risk factors. All isolates except Candida krusei were 100% susceptible to amphotericin-B. Resistance rate was high against itraconazole and Ketoconazole 55(57.3%).ConclusionThe prevalence of Candida species among symptomatic pregnant women was significantly higher than asymptomatic pregnant women. Age group between 26 and 40 years was significantly associated with Candida infection. Amphotericin B was the most sensitive antifungal drug. High rate of multiple drugs resistant Candida species was detected. Therefore Symptomatic women should be routinely screened and treated.

Highlights

  • Candida is a fungal pathogen and the commonest opportunistic fungi in human [1]

  • The present study showed that the overall prevalence of Candida species among pregnant women 25% was similar with a study done in Nigeria (24%) [26] and Saudi Arabia (26%) [28]

  • The present study revealed that prevalence of Candida was higher in women who were using contraceptives (30.3%) than non-users (12.8%),this finding was similar with a report in India with 20.51 and 13.52%, Table 3 Association of variables with Candida colonization among pregnant women at Debre Markos Referral hospital, Northwest Ethiopia, May2017

Read more

Summary

Introduction

Candida is a fungal pathogen and the commonest opportunistic fungi in human [1]. The genus Candida has over 350 heterogeneous species, but only a few of them have been known to cause an opportunistic human disease [2]. Candida species are normal floras in mucosal surfaces of the human gastrointestinal tract, genitourinary tract, and mouth. It causes different types of diseases ranging from superficial infection to life threatening invasive and haematogenic infections [7]. Vaginal candidiasis is the most common type of fungal disease all over the world which affects the genital tract of women [8, 9]. Whereas complicated vaginal candidiasis is mostly caused by non-albicans Candida species and are common among immune-compromised individuals and pregnant women [10]. ; In Ethiopia, due to scarcity of data, much has not been documented regarding the prevalence of Candida among pregnant women

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call